Philips Medical Systems chose opening day of the ECR to release the world’s first commercial time-of-flight PET/CT system. The system, scheduled to begin shipping to sites in Europe and the U.S. in June, will more than double image sensitivity, according to the company, allowing users to either markedly improve image quality or cut scan time by a third or more.
Philips Medical Systems chose opening day of the ECR to release the world's first commercial time-of-flight PET/CT system. The system, scheduled to begin shipping to sites in Europe and the U.S. in June, will more than double image sensitivity, according to the company, allowing users to either markedly improve image quality or cut scan time by a third or more.
Imagers will be able to perform whole-body PET scans with the Gemini TF (True Flight) in less than 10 minutes, compared with 15 minutes or longer using conventional systems. This will hold true even for obese patients, who generally require additional scan time on conventional systems, said Jim Cavanaugh, director of global marketing for Philips Nuclear Medicine PET/CT.
Users of the Gemini TF could instead acquire data for the usual time period and generate images with increased sensitivity or specificity, said Piotr Maniawski, Philips' senior marketing manager for PET/CT development.
"Those who don't care about time can choose to spend the usual length of a procedure and get a lot better image quality than they can today," he said.
Philips has been testing beta versions of the new scanner since November, Maniawski said. Studies have produced enough data to make the Philips team confident the technology can meet its clinical potential, Cavanaugh said.
Trade-offs in time and image quality, along with the algorithms built into Gemini TF, offer the possibility of fine-tuning a scan to meet differing clinical needs. Images can be acquired with the same diagnostic quality as current ones but in a third less time. Or time can be held constant but noise cut in half, while holding contrast resolution at a constant. Alternatively, contrast can be enhanced, while keeping noise at a constant.
If physicians want to use the system to detect absolutely everything, they could create an image with high contrast and a standard amount of noise. If they want to check whether a suspected lesion is, in fact, cancer, they could choose a less noisy image with lower contrast to visualize only the larger, more aggressive tumors.
"It is all a trade-off between specificity and sensitivity," Cavanaugh said. "It is really how the user wants the system to perform."
With a CE mark and FDA clearance in hand, Philips chose to unveil the product at the ECR with follow-up showings at Academy of Molecular Imaging and Society of Nuclear Medicine conferences leading up to its routine shipping start in June. Regulatory clearances for Japan and China are expected in the fourth quarter of 2006.
Study: Emerging AI Platform for DBT Shows 23 Percent Increase in Breast Cancer Detection Rate
March 23rd 2023In a recent video interview, Kathy Schilling, M.D., discussed findings from a study of ProFound AI, an adjunctive artificial intelligence (AI) software for digital breast tomosynthesis (DBT), that demonstrated a 23 percent increase in breast cancer detection in comparison to DBT alone.
Study: AI Improves Cancer Detection Rate for Digital Mammography and Digital Breast Tomosynthesis
March 6th 2023Comparing year-long findings with and without adjunctive artificial intelligence (AI) at a breast cancer screening program in Spain, researchers found the combination of digital breast tomosynthesis and AI had a 92.5 percent accuracy for diagnosing cancer in patients with elevated risk.
Canon Medical Launches New CT and X-Ray Modalities at ECR 2023
March 2nd 2023The new launches include the 80/160-slice computed tomography (CT) scanner Aquilion Serve, which allows simultaneous previews of axial, lateral and AP views, and Celex, a multipurpose X-ray system that offers automated and customizable features to help maximize workflow efficiencies.